Healthcare stocks are moderately higher, with the NYSE
Healthcare Sector Index adding 0.6% and shares of healthcare
companies in the S&P 500 rising 0.4% as a group.
In company news, Ariad Pharmaceuticals (
) is plunging for a second time this week, falling nearly 19% to
$4.42 a share as investors again respond to the U.S. Food and Drug
Administration says it is investigating reports of blood clots in
some patients using the company's leukemia drug candidate.
In an online posting, the FDA said doctors should weigh the
risks and benefits of treating patients with Iclusig, adding
patients taking the drug "should seek immediate medical attention
if they experience chest pain or pressure or other symptoms of
The agency Wednesday said it was temporarily shelving clinical
testing of Iclusig after the company reported nearly 12% of
patients treated with the drug developed dangerous blood clots - a
50% jump over previous reports of side effects linked to the
In other sector news,
(+) ANGO, (+1.8%) Non-GAAP adjusted earnings of $0.12 per share
beat by $0.07 while its $83.6 mln in net sales top analyst
estimates by $1.1 mln. Raises EPS, sales forecasts for Q2 and FY14
above Street consensus.
(-) ASTM, (-15.8%) Announces 20-for-1 reverse stock split in a
move intended to lift stock price above $1 Nasdaq minimum
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.